Ultragenyx Pharmaceutical, Inc. (RARE)

36.23 +0.03 (+0.08%) USD  |  NASDAQ  |  Dec 12, 16:00
36.24 +0.01 (+0.03%) After-Hours: 20:00
More

Ultragenyx Pharmaceutical Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade